OpGen, Inc.: OpGen Announces Pricing of $7.5 Million Public Offering

ROCKVILLE, Md., Jan. 06, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, "OpGen" or "the Company"), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to

Related Keywords

Rockville ,New York ,United States ,Russia ,Ukraine ,Matthew Bretzius ,Oliver Schacht ,Curetis Gmb ,Opgen Press Contact ,Technology Platform ,Opgen Inc ,Nasdaq ,Edison Group ,Exchange Commission ,Securities Exchange ,Gene Panel ,Hc Wainwright Co ,European Investment Bank ,Unyvero Platform ,Ares Genetics ,United Statesa ,Curetis Gmbh ,Ares Genetics Gmbh ,Securities Act ,Securities Exchange Act ,Private Securities Litigation Reform Act ,Nasdaq Capital Market ,Gen Press Contact ,Tank Marketing ,Gen Investor Contact ,Opgen ,Nnounces ,Ricing ,Billion ,Public ,Offering ,